The Johnson & Johnson Vaccine Pause Expl...

SpaceX, Elon Musk’s rocket and satellite maker, is set to go public and begin selling shares as soon as next week. Ryan Mac, who reports on business, explains the plan for the company’s expected record-shattering debut on the stock market, and how it is changing the rules for inv ... Show More

In the lead-up to America’s 250th anniversary, President Trump is spending hundreds of millions of dollars on a major renovation of the nation’s capitol. David A. Fahrenthold, who has been investigating how the projects have come together, takes listeners on a walking tour of the ... Show More

Olivia Rodrigo sat down with Joe and Jon for her first in-depth conversation about her new album, “you seem pretty sad for a girl so in love,” out June 12. She discussed the many ways her creative process intersects with the extracurricular noise of pop superstardom, whether its ... Show More

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ... Show More

The Centers for Disease Control and Prevention and the Food and Drug Administration announced a recommended pause in use of Johnson & Johnson's single-use COVID-19 vaccine, while the agencies investigate reports of a rare but serious blood clot in six people. The pause comes at a ... Show More

The CDC and the FDA have lifted their recommended pause on the Johnson and Johnson COVID vaccine, and added a warning label about the very, very rare reported cases of blood clots. But overall vaccination rates in the US are slowing down, indicating that while supply is increasin ... Show More

The U.S. Food and Drug administration found the Johnson & Johnson coronavirus vaccine is safe and effective and meets the emergency use authorization requirements. If authorized, it’ll be the third shot option in the United States. Dr. Leana Wen is the former Baltimore Health Com ... Show More

Zack, Jenn, and Alex discuss the raft of problems stymying Europe’s vaccine rollout, which has been slower and messier than expected, given some of the earlier successes the continent had controlling infection rates. They talk about why some countries decided to pause administeri ... Show More

Short Wave's Emily Kwong talks with NPR health correspondent Allison Aubrey about some of the latest coronavirus news, including the return of the Johnson & Johnson vaccine in the U.S. and vaccine outreach in harder to reach communities.Have questions about the latest coronavirus ... Show More

A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. Combined with the two vaccines curren ... Show More

The FDA vaccine advisers recommended authorization of Johnson & Johnson’s coronavirus vaccine. In the U.S., the single-shot showed an overall efficacy of 72% in preventing moderate to severe disease and 85% effective in preventing severe disease. CNN’s Chief Medical Correspondent ... Show More

Joe Biden has a history of racist comments. Amazon is testing new technology that uses the palm of your hand to identify shoppers. China has a new vaccine that has not been working particularly well, especially in Chile. The Pfizer vaccine now has a side effect of its own, causin ... Show More